Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
16,629,429
-
Total 13F shares
-
174,000
-
Share change
-
+34,674
-
Total reported value
-
$7,452,569
-
Price per share
-
$42.83
-
Number of holders
-
10
-
Value change
-
+$1,936,743
-
Number of buys
-
9
-
Number of sells
-
4
Institutional Holders of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) as of Q4 2025
As of 31 Dec 2025,
RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
174,000 shares.
The largest 10 holders included
MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Hennion & Walsh Asset Management, Inc., Range Financial Group LLC, SG Americas Securities, LLC, Brookwood Investment Group LLC, GAMMA Investing LLC, FLAGSHIP HARBOR ADVISORS, LLC, NISA INVESTMENT ADVISORS, LLC, True Wealth Design, LLC, and SJS Investment Consulting Inc..
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.